162 related articles for article (PubMed ID: 29056726)
1. p16, pRb, and p53 in Feline Oral Squamous Cell Carcinoma.
Supsavhad W; Dirksen WP; Hildreth BE; Rosol TJ
Vet Sci; 2016 Aug; 3(3):. PubMed ID: 29056726
[TBL] [Abstract][Full Text] [Related]
2. Expression of mPGES1 and p16 in feline and human oral squamous cell carcinoma: A comparative oncology approach.
Nasry WHS; Jones K; Rodriguez-Lecompte JC; Tesch M; Martin CK
Vet Comp Oncol; 2024 Jun; 22(2):204-216. PubMed ID: 38378135
[TBL] [Abstract][Full Text] [Related]
3. A virome sequencing approach to feline oral squamous cell carcinoma to evaluate viral causative factors.
Chu S; Wylie TN; Wylie KM; Johnson GC; Skidmore ZL; Fleer M; Griffith OL; Bryan JN
Vet Microbiol; 2020 Jan; 240():108491. PubMed ID: 31902496
[TBL] [Abstract][Full Text] [Related]
4. Loss of retinoblastoma protein, but not p53, is associated with the presence of papillomaviral DNA in feline viral plaques, Bowenoid in situ carcinomas, and squamous cell carcinomas.
Munday JS; Aberdein D
Vet Pathol; 2012 May; 49(3):538-45. PubMed ID: 21930804
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Features of Epithelial-Mesenchymal Transition in Feline Oral Squamous Cell Carcinoma.
Harris K; Gelberg HB; Kiupel M; Helfand SC
Vet Pathol; 2019 Nov; 56(6):826-839. PubMed ID: 31331247
[TBL] [Abstract][Full Text] [Related]
6. Detection of Felis catus papillomavirus type-2 DNA and viral gene expression suggest active infection in feline oral squamous cell carcinoma.
Altamura G; Cardeti G; Cersini A; Eleni C; Cocumelli C; Bartolomé Del Pino LE; Razzuoli E; Martano M; Maiolino P; Borzacchiello G
Vet Comp Oncol; 2020 Dec; 18(4):494-501. PubMed ID: 31989718
[TBL] [Abstract][Full Text] [Related]
7. Analysis of DNA methylation and TP53 mutational status for differentiating feline oral squamous cell carcinoma from non-neoplastic mucosa: A preliminary study.
Renzi A; Morandi L; Lenzi J; Rigillo A; Bettini G; Bellei E; Giacomini A; Tinto D; Sabattini S
Vet Comp Oncol; 2020 Dec; 18(4):825-837. PubMed ID: 32506786
[TBL] [Abstract][Full Text] [Related]
8. A multi-institutional epidemiologic study evaluating environmental risk factors for feline oral squamous cell carcinoma.
Noall L; Lee S; Burton JH; Marquardt TM; Cermak J; Thombs LA; Rogic AM; Bryan JN; Chu S
Vet Comp Oncol; 2023 Sep; 21(3):509-519. PubMed ID: 37243409
[TBL] [Abstract][Full Text] [Related]
9. Increased p16
Munday JS; He Y; Aberdein D; Klobukowska HJ
Vet J; 2019 Jun; 248():64-70. PubMed ID: 31113565
[TBL] [Abstract][Full Text] [Related]
10. Validation of oral brushing as a non-invasive technique for the identification of feline oral squamous cell carcinoma by DNA methylation and TP53 mutation analysis.
Renzi A; Morandi L; Bellei E; Marconato L; Rigillo A; Aralla M; Lenzi J; Bettini G; Tinto D; Sabattini S
Vet Comp Oncol; 2021 Sep; 19(3):501-509. PubMed ID: 33624422
[TBL] [Abstract][Full Text] [Related]
11. Feline Oral Squamous Cell Carcinoma: A Critical Review of Etiologic Factors.
Sequeira I; Pires MDA; Leitão J; Henriques J; Viegas C; Requicha J
Vet Sci; 2022 Oct; 9(10):. PubMed ID: 36288171
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of feline oral squamous cell carcinomas for p16CDKN2A protein immunoreactivity and the presence of papillomaviral DNA.
Munday JS; Knight CG; French AF
Res Vet Sci; 2011 Apr; 90(2):280-3. PubMed ID: 20621320
[TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR monoclonal antibody Cetuximab displays potential anti-cancer activities in feline oral squamous cell carcinoma cell lines.
Altamura G; Borzacchiello G
Front Vet Sci; 2022; 9():1040552. PubMed ID: 36467642
[TBL] [Abstract][Full Text] [Related]
14. Genomic landscape and gene expression profiles of feline oral squamous cell carcinoma.
Rodney AR; Skidmore ZL; Grenier JK; Griffith OL; Miller AD; Chu S; Ahmed F; Bryan JN; Peralta S; Warren WC
Front Vet Sci; 2023; 10():1079019. PubMed ID: 37266381
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical studies on Waf1p21, p16, pRb and p53 in human esophageal carcinomas and neighboring epithelia from a high-risk area in northern China.
Yang G; Zhang Z; Liao J; Seril D; Wang L; Goldstein S; Yang CS
Int J Cancer; 1997 Sep; 72(5):746-51. PubMed ID: 9311588
[TBL] [Abstract][Full Text] [Related]
16. Involvement of
Ito S; Chambers JK; Sumi A; Yamashita-Kawanishi N; Omachi T; Haga T; Nakayama H; Uchida K
Vet Pathol; 2022 Jan; 59(1):63-74. PubMed ID: 34510979
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic Targeting of Protein Kinase CK2 Gene Expression in Feline Oral Squamous Cell Carcinoma: A Naturally Occurring Large-Animal Model of Head and Neck Cancer.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Hum Gene Ther Clin Dev; 2017 Jun; 28(2):80-86. PubMed ID: 28335614
[TBL] [Abstract][Full Text] [Related]
18. Combining radiation therapy with zoledronate for the treatment of osteo-invasive feline oral squamous cell carcinoma.
Lundberg AP; Tran Hoang C; Billhymer A; Selting KA
Vet Comp Oncol; 2022 Dec; 20(4):788-796. PubMed ID: 35561080
[TBL] [Abstract][Full Text] [Related]
19. Increased p16CDKN2A protein within feline cutaneous viral plaques, bowenoid in situ carcinomas, and a subset of invasive squamous cell carcinomas.
Munday JS; French AF; Peters-Kennedy J; Orbell GM; Gwynne K
Vet Pathol; 2011 Mar; 48(2):460-5. PubMed ID: 20587686
[TBL] [Abstract][Full Text] [Related]
20. Feline head and neck squamous cell carcinoma cell line: characterization, production of parathyroid hormone-related protein, and regulation by transforming growth factor-beta.
Tannehill-Gregg S; Kergosien E; Rosol TJ
In Vitro Cell Dev Biol Anim; 2001; 37(10):676-83. PubMed ID: 11776973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
